Your browser doesn't support javascript.
loading
Manejo hemodinámico intraoperatorio con esmolol durante la extirpación de un feocromocitoma bilateral en una paciente de 10 años / Esmolol to control hemodynamic response during removal of a bilateral pheochromocytoma from a 10-year-old girl
Rodríguez González, O; Amador García, I; Martín Iglesias, A; Rodríguez Germa, I; Besada Estévez, J. C.
Affiliation
  • Rodríguez González, O; Hospital Universitario Nuestra Señora de Candelaria. Santa Cruz de Tenerife. España
  • Amador García, I; Hospital Universitario Nuestra Señora de Candelaria. Santa Cruz de Tenerife. España
  • Martín Iglesias, A; Hospital Universitario Nuestra Señora de Candelaria. Santa Cruz de Tenerife. España
  • Rodríguez Germa, I; Hospital Universitario Nuestra Señora de Candelaria. Santa Cruz de Tenerife. España
  • Besada Estévez, J. C; Hospital Universitario Nuestra Señora de Candelaria. Santa Cruz de Tenerife. España
Rev. esp. anestesiol. reanim ; 57(7): 454-457, ago.-sept. 2010. ilus
Article in Spanish | IBECS | ID: ibc-81190
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Los feocromocitomas son tumores derivados de lascélulas cromafines, que pueden secretar grandes cantidadesde catecolaminas. Su incidencia es baja, 2-8 casospor millón de habitantes, solamente un 10% de éstos sedan en edad infantil. Para el tratamiento perioperatoriocorrecto se requiere un conocimiento profundo desu fisiopatología, y de la farmacología implicada. Haygran cantidad de información publicada sobre fármacosque pueden utilizarse pero no tan extensa en niños.En los últimos años se han ido desarrollando nuevosfármacos entre los que se encuentran el esmolol, unbeta bloqueante de acción corta. Presentamos un casode tratamiento intraoperatorio con esmolol en unapaciente de 10 años programada para la extirpación deun feocromocitoma bilateral(AU)
ABSTRACT
Pheochromocytomas, which derive from chromaffincells, can secrete catecholamines in large amounts. Theincidence of these tumors is low at 2 to 8 cases permillion population and only 10% of cases occur inchildren. A thorough understanding of thepathophysiology of these tumors and the consequenteffect of drugs will be necessary for treating thesepatients during the perioperative period. A great dealhas been published on drugs that can be used in thissetting, but only a small portion of the information isrelevant to children. Esmolol, a short-action -blocker,figures among the drugs that have been developed inrecent years. We report a case in which esmolol was usedduring surgery in a 10-year-old girl undergoingscheduled removal of a bilateral pheochromocytoma(AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Pheochromocytoma / Preanesthetic Medication / Laparoscopy / Hypnosis, Anesthetic / Intraoperative Period / Isoflurane / Anesthesia Limits: Child / Female / Humans Language: Spanish Journal: Rev. esp. anestesiol. reanim Year: 2010 Document type: Article Institution/Affiliation country: Hospital Universitario Nuestra Señora de Candelaria/España
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Pheochromocytoma / Preanesthetic Medication / Laparoscopy / Hypnosis, Anesthetic / Intraoperative Period / Isoflurane / Anesthesia Limits: Child / Female / Humans Language: Spanish Journal: Rev. esp. anestesiol. reanim Year: 2010 Document type: Article Institution/Affiliation country: Hospital Universitario Nuestra Señora de Candelaria/España
...